These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

562 related items for PubMed ID: 34244988

  • 1. An Update on the Management of Childhood-Onset Systemic Lupus Erythematosus.
    Trindade VC, Carneiro-Sampaio M, Bonfa E, Silva CA.
    Paediatr Drugs; 2021 Jul; 23(4):331-347. PubMed ID: 34244988
    [Abstract] [Full Text] [Related]

  • 2. Pharmacological Management of Childhood-Onset Systemic Lupus Erythematosus.
    Thorbinson C, Oni L, Smith E, Midgley A, Beresford MW.
    Paediatr Drugs; 2016 Jun; 18(3):181-95. PubMed ID: 26971103
    [Abstract] [Full Text] [Related]

  • 3. [Treatment of systemic lupus erythematosus: myths, certainties and doubts].
    Ruiz-Irastorza G, Danza A, Khamashta M.
    Med Clin (Barc); 2013 Dec 21; 141(12):533-42. PubMed ID: 23622892
    [Abstract] [Full Text] [Related]

  • 4. B-cell targeted therapies in systemic lupus erythematosus: successes and challenges.
    Harvey PR, Gordon C.
    BioDrugs; 2013 Apr 21; 27(2):85-95. PubMed ID: 23456653
    [Abstract] [Full Text] [Related]

  • 5. Safety and efficacy of biologics in childhood systemic lupus erythematosus: a critical systematic review.
    Elshaer R, Jaber S, Odeh N, Arbili L, Al-Mayouf SM.
    Clin Rheumatol; 2024 Mar 21; 43(3):863-877. PubMed ID: 38079010
    [Abstract] [Full Text] [Related]

  • 6. [EULAR recommendations 2023 on the treatment of systemic lupus erythematosus -Implications for treatment in Germany].
    Mucke J, Aringer M.
    Z Rheumatol; 2024 Aug 21; 83(6):431-438. PubMed ID: 39037547
    [Abstract] [Full Text] [Related]

  • 7. EULAR recommendations for the management of systemic lupus erythematosus: 2023 update.
    Fanouriakis A, Kostopoulou M, Andersen J, Aringer M, Arnaud L, Bae SC, Boletis J, Bruce IN, Cervera R, Doria A, Dörner T, Furie RA, Gladman DD, Houssiau FA, Inês LS, Jayne D, Kouloumas M, Kovács L, Mok CC, Morand EF, Moroni G, Mosca M, Mucke J, Mukhtyar CB, Nagy G, Navarra S, Parodis I, Pego-Reigosa JM, Petri M, Pons-Estel BA, Schneider M, Smolen JS, Svenungsson E, Tanaka Y, Tektonidou MG, Teng YO, Tincani A, Vital EM, van Vollenhoven RF, Wincup C, Bertsias G, Boumpas DT.
    Ann Rheum Dis; 2024 Jan 02; 83(1):15-29. PubMed ID: 37827694
    [Abstract] [Full Text] [Related]

  • 8. Systemic Lupus Erythematosus: A Review.
    Siegel CH, Sammaritano LR.
    JAMA; 2024 May 07; 331(17):1480-1491. PubMed ID: 38587826
    [Abstract] [Full Text] [Related]

  • 9. Update on the pathogenesis and treatment of childhood-onset systemic lupus erythematosus.
    Couture J, Silverman ED.
    Curr Opin Rheumatol; 2016 Sep 07; 28(5):488-96. PubMed ID: 27341622
    [Abstract] [Full Text] [Related]

  • 10. European evidence-based recommendations for the diagnosis and treatment of childhood-onset lupus nephritis: the SHARE initiative.
    Groot N, de Graeff N, Marks SD, Brogan P, Avcin T, Bader-Meunier B, Dolezalova P, Feldman BM, Kone-Paut I, Lahdenne P, McCann L, Özen S, Pilkington CA, Ravelli A, Royen-Kerkhof AV, Uziel Y, Vastert BJ, Wulffraat NM, Beresford MW, Kamphuis S.
    Ann Rheum Dis; 2017 Dec 07; 76(12):1965-1973. PubMed ID: 28877866
    [Abstract] [Full Text] [Related]

  • 11. Update οn the diagnosis and management of systemic lupus erythematosus.
    Fanouriakis A, Tziolos N, Bertsias G, Boumpas DT.
    Ann Rheum Dis; 2021 Jan 07; 80(1):14-25. PubMed ID: 33051219
    [Abstract] [Full Text] [Related]

  • 12. Belimumab in childhood systemic lupus erythematosus: A review of available data.
    Chen F, Zheng Y, Chen X, Wen Z, Xu Y, Yang J, Xu K.
    Front Immunol; 2022 Jan 07; 13():940416. PubMed ID: 35967351
    [Abstract] [Full Text] [Related]

  • 13. Efficacy of belimumab for severe childhood-onset systemic lupus erythematosus with diffuse proliferative glomerulonephritis: A case report.
    Hu Y, Yuan J, Wang B, Ma L, Zha Y.
    Medicine (Baltimore); 2023 Aug 25; 102(34):e34800. PubMed ID: 37653777
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effect of belimumab treatment on renal outcomes: results from the phase 3 belimumab clinical trials in patients with SLE.
    Dooley MA, Houssiau F, Aranow C, D'Cruz DP, Askanase A, Roth DA, Zhong ZJ, Cooper S, Freimuth WW, Ginzler EM, BLISS-52 and -76 Study Groups.
    Lupus; 2013 Jan 25; 22(1):63-72. PubMed ID: 23263865
    [Abstract] [Full Text] [Related]

  • 16. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis.
    Fanouriakis A, Kostopoulou M, Cheema K, Anders HJ, Aringer M, Bajema I, Boletis J, Frangou E, Houssiau FA, Hollis J, Karras A, Marchiori F, Marks SD, Moroni G, Mosca M, Parodis I, Praga M, Schneider M, Smolen JS, Tesar V, Trachana M, van Vollenhoven RF, Voskuyl AE, Teng YKO, van Leew B, Bertsias G, Jayne D, Boumpas DT.
    Ann Rheum Dis; 2020 Jun 25; 79(6):713-723. PubMed ID: 32220834
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Allergo-immunology. Clinical immunology].
    Chizzolini C.
    Rev Med Suisse; 2012 Jan 11; 8(323):11-3. PubMed ID: 22303732
    [Abstract] [Full Text] [Related]

  • 20. Differences in Clinical Features and Mortality between Childhood-onset and Adult-onset Systemic Lupus Erythematosus: A Prospective Single-center Study.
    Joo YB, Park SY, Won S, Bae SC.
    J Rheumatol; 2016 Aug 11; 43(8):1490-7. PubMed ID: 27252431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 29.